Prof David Virshup shares a group photo with his lab // Credit: Duke-NUS
Inspiring the next generation
Virshup has also taken his research one step further by developing a drug, ETC-159, that prevents PORCN from triggering Wnt signalling, offering hope to patients with Wnt-addicted cancers.
With this drug, his team has made further discoveries, such as why stromal cells in the intestines are resistant to Wnt inhibitors—a finding that made the cover of a 2018 issue of Developmental Cell, as well as their recent breakthrough on why some pancreatic and colorectal tumours resist targeted anti-Wnt drugs.
While he is proud of what he has accomplished, what gives Virshup the most satisfaction is seeing students and junior researchers mature under his guidance.
For fellow clinician-scientist Kabiri, her time in Virshup’s lab has inspired her to be meticulous in her research, just like Virshup. “The level of detail he applies to troubleshooting is incredible—he will break down the experiments reagent by reagent to help you determine what went wrong.
“And because he’s trained as a doctor, he’s always thinking about the body as a whole and how we have to do everything at the physiological level, so it was fun and inspiring to learn from him.”
Echoing the same sentiments, Dr Xu Peng, a former graduate student from Virshup’s lab previously, added: “The joy of doing science in his lab has motivated me to continue my scientific career in academia, with the hopes that someday I will become a great scientist like him.”